Sitemap
December 11, 2017 Articles
Filter by Available Specialty
- 2 decades of diabetes and CVD
- 50 years of heart transplant: Progress in immunosuppression, survival rates
- 6 recent articles discussing hypertension guideline, treatment
- Add-on dapagliflozin therapy safe, effective in Asian adults with poorly controlled type 2 diabetes
- Atezolizumab-based triplet effective, but toxic, for follicular lymphoma
- BLOG: Evolution of diagnostics and imaging in glaucoma
- BLU-285 induces rapid responses in advanced systemic mastocytosis
- Brentuximab vedotin combination superior to standard chemotherapy in Hodgkin lymphoma
- Cardiac arrhythmias: An emerging issue with anticancer drugs
- Celiac symposium highlights importance of research, community partnerships
- Changes in plasma glucose markers may mediate CV risk reduction with empagliflozin
- Circulating tumor DNA reliably measures lymphoma disease burden
- Despite milder symptoms, subset patients with ILE require treatment comparable to SLE
- Development of angioplasty spawned 40 years of innovation, exploration
- Duvelisib extends PFS in relapsed or refractory chronic lymphocytic leukemia
- Extracorporeal cellular therapy unsuccessful in treating alcoholic hepatitis
- Fatty liver index useful for predicting precancerous colon polyps
- FDA accepts supplemental biologics license application for 12-week dosing of Eylea
- FDA approves short-acting insulin Admelog for type 2 diabetes
- Few providers discuss glaucoma drug costs with patients
- 'Future looks bright' for combination of venetoclax, obinutuzumab in chronic lymphocytic leukemia
- Graft failure remains concern following umbilical cord blood transplantation for leukemia
- High blood cobalt, chromium levels had no cardiotoxic effect on patients with MoM implants
- High-throughput sequencing aids in diagnosis of bleeding, platelet disorders
- Household opioid availability increases risk for use
- Ibrutinib plus venetoclax shows promise for chronic lymphocytic leukemia
- IDSA withholds support for international sepsis guidelines
- Impact of PCI vs. CABG on outcomes varies by acuity of presentation in diabetes
- Impaired auditory stimuli inhibition linked to features of schizophrenia
- Inclusive criteria, generic drugs effective for HCV in limited resource nations
- Individualizing blood glucose goals cuts costs, improves quality of life
- Insulin demand higher in children with type 1 diabetes plus asthma
- Lower plasma NT-proBNP levels common in black patients
- New process may detect the health of a donated kidney
- Novartis net income increases to $2.1 billion in third quarter
- Ocular Therapeutix posts $15.6 million quarterly loss
- Omega-3 eye drop improves ocular dryness symptoms
- 'Peppa Pig' may skew children's view of health care
- Physicians must create safe, trusting environment for sexual assault victims
- Prognostic discussions may improve relationship between oncologists, patients with cancer
- Serious infection rate low in patients with RA treated with biologic DMARDs, denosumab
- SIGA Technologies submits NDA for oral smallpox treatment
- Similar outcomes seen after TKA with vs without prior arthroscopic surgery
- Survey: Physicians rate weight-loss medications, surgery less effective than lifestyle in obesity management
- Transapical TAVR risky in patients with LV dysfunction
- Transdiagnostic subtypes link symptoms, behavior, function
- Trial Scorecard: CULPRIT-SHOCK
- Trial Scorecard: DACAB
- Trial Scorecard: DKCRUSH-V
- Trial Scorecard: HOPE-Duchenne
- Trial Scorecard: ORBITA
- Trial Scorecard: PROPEL
- Trial Scorecard: REDUCE LAP-HF
- Trial Scorecard: TRICS III
- Tricuspid valve surgeries increased from 2004 to 2013
- Vitamin D intake improves birth rates in women undergoing assisted reproductive treatment
- Young children may be at risk of injury, fatality from window blinds